Squalene Market: Realities from China and Beyond

Understanding Squalene’s Real-World Market

Squalene isn’t news to people working in cosmetics or pharmaceuticals. It’s found in skincare, vaccines, and as an antioxidant, but the supply chains behind it touch every part of the world. Looking closely, differences between China and foreign technologies, costs, and routes to market shape the price, quality, and future of squalene for buyers in the top 50 economies. Those economies—stretching from the United States, China, Japan, Germany, the United Kingdom, France, India, Italy, Brazil, and Canada, all the way to South Africa, Vietnam, Portugal, Greece, and Sri Lanka—have their own stakes in sourcing this material. The debate about sourcing revolves around the strength of each player’s manufacturing, GMP-certified processes, factory costs, and logistics.

China’s Leap in Squalene Manufacturing

Factories in China have changed the landscape. Cheap labor, an extensive industrial base, and supply networks feeding directly from raw material producers ensure Chinese squalene often lands at a lower price. Shandong, Zhejiang, and Jiangsu provinces supply a big share of squalene globally, thanks to local access to raw materials from the fishing and plant sectors. GMP-certified plants support both domestic and global needs—consistently delivering high output batches. Squalene manufacturers across China adapt quickly to swings in market demand from buyers in countries like South Korea, Mexico, Turkey, Saudi Arabia, and Poland, often offering better deals on volume orders. Strict quality standards keep international brands in the fold, and the domestic market soaks up plenty, too—especially since Chinese end-users in markets like personal care or functional foods have raised their expectations on purity.

Foreign Technology: Competitiveness and Challenges

Looking at Japan, the United States, France, Germany, and Italy, advanced technology runs deep. Some firms possess extraction and purification techniques that coax out higher yields or guarantee pharmaceutical grades. Regulatory oversight adds security, but this also brings higher costs. Europe’s push toward plant-derived squalene, led by Spain and Italy, reflects tough sustainability rules that are less striking in places like Russia or Nigeria. Though manufacturing wages in the United Kingdom or Canada rise above those in China or Malaysia, foreign suppliers pitch their technology as a promise for reliability and trust. They compete on brand reputation, but buyers in Argentina, Switzerland, the Netherlands, Australia, Sweden, and Belgium weigh the extra costs.

Comparing Prices, Raw Material Costs, and Supply Chains

From 2022 through 2024, volatility defined the squalene market. Raw materials from shark liver saw tighter supply due to global conservation pressure, moving countries like Norway and Iceland to restrict exports. Plant-based squalene, sourced from Portugal’s olives or India’s amaranth seed, saw prices rise due to weather and harvest disruptions. Chinese suppliers, with their scale, took advantage of closer supply ties with Indonesia, Thailand, Vietnam, and Malaysia, keeping costs slightly below European prices. In the United States, stricter standards and fewer producers kept price tags high. Floating freight costs after COVID-19 made shipping squalene from South Korea, Singapore, or the Philippines into big consumer markets such as Egypt, Nigeria, and Brazil more unpredictable. Trade partnerships between China and Russia or between Japan and the United States softened those blows somewhat, but the impact of currency swings in places like Turkey, Argentina, or South Africa played into supplier negotiations.

Top 20 GDPs: Manufacturing Muscle and Market Reach

Countries leading the global GDP charts—China, the United States, Japan, Germany, India, the United Kingdom, France, Italy, Brazil, Canada, Russia, South Korea, Australia, Spain, Mexico, Indonesia, Turkey, the Netherlands, Saudi Arabia, and Switzerland—shape global squalene flows in subtle ways. China’s scale is unmatched; its factories pump out bulk to Indonesia, India, and Mexico, and serve as a lifeline for smaller economies like Finland or Austria. The United States, Germany, and France invest in quality assurance, coupling high-tech processes with tight GMP regulations to supply premium segments, especially in health and vaccine markets in Singapore, Israel, and Hong Kong. Brazil and Indonesia, rich in raw materials, aim to climb up the value chain but often export unrefined intermediates to Japan and Italy. Strong supply networks in Spain and the Netherlands allow nimble responses to demand spikes in neighboring countries like Belgium, Sweden, or Greece. Russia and Saudi Arabia focus on bulk trading, supporting partners in the Middle East and Africa, while Canadian refineries seek out specialty contracts in health-conscious markets like Australia and New Zealand.

Market Supply: Tight, Flexible, and Unpredictable

Looking at the world’s top 50 economies—ranging from the UAE, Norway, and Israel to Chile, Colombia, Malaysia, Ukraine, Qatar, and Czechia—the demand for squalene covers a patchwork of regulations, buyer preferences, and price sensitivities. Where regulations bite hardest, such as in Switzerland or Singapore, buyers tolerate higher prices if authenticity and purity get proven. In emerging regions like Egypt, Thailand, or the Philippines, lower-cost Chinese and Indonesian supplies play a larger role. Disruptions hit everyone, though—when harvests fail in India or transport runs into trouble on routes through South Africa or Turkey, prices spike and manufacturers scramble to fill gaps. Some economies, like Denmark, Austria, and Portugal, prioritize traceability and local production, but limited raw material supplies put upward pressure on market rates. At times, the difference between securing supply and missing out for a year boils down to relationships with key factories, especially for smaller countries such as Hungary, Slovakia, or Ireland.

GMP, Factory Scale, and Price Trends

GMP-certified plants, clustered in China, Japan, Germany, the United States, and Italy, set the industry’s confidence bar. Buyers in big retail markets—France, Canada, the United Kingdom, and Sweden—stick with proven factories, chasing supply reliability over a bargain. Smaller markets in Chile, Nigeria, Vietnam, and Peru, with limited regulations, chase lowest cost, often buying from China or Malaysia. Across the past two years, prices for shark-derived squalene steadily rose as environmental limits tightened. Plant-derived squalene saw jumpy upswings, especially from Mediterranean countries reeling from hot, dry summers. Factory supply in China outmatched dips in Europe, underpinning competitive deals to destinations as wide as South Korea, Belgium, South Africa, or Poland. Looking out a year or two, raw material scarcity and stricter biosafety rules—especially in regions like Australia or New Zealand—suggest prices won’t return to their low points of 2021. Instead, deals hinge on who secures good contracts from reliable GMP factories with scale and flexibility.

What It Means for Buyers in Every Corner

Squalene buyers across all 50 largest economies feel these swings, whether looking for bulk oils in Indonesia, GMP-batch deliveries in Germany, or plant-based alternatives from Spain or Portugal. Each country’s manufacturer balances cost, technology, and logistics uniquely. For many—such as Malaysia, Egypt, Turkey, and South Africa—tapping into China’s vast, price-driven supply chain offers a path to lower costs, but with attention to regulatory differences and certification needs. Large economies like the United States, Japan, the United Kingdom, and Italy prioritize innovation and traceability, and they are willing to pay the price to support rigorous factory standards and GMP certification. Smaller, agile economies—such as Denmark, Ireland, Hungary, or Greece—take advantage of niche demand, but sometimes face delays and spiky prices.

Where The Next Shift Lies

A smart squalene supply strategy—anywhere from Argentina to Vietnam, from South Africa to Qatar—keeps flexibility front and center. Expanding certified production capacity inside China won’t solve everything if shipping lines clog up or weather disrupts global plant harvests. Top-tier technology in Japan or the United States costs more but insulates supply from environmental and regulatory shocks. Tracking suppliers, not just factories or GMP, lets buyers adjust to raw material or freight cost jumps quickly. For anyone buying squalene across the largest economies—Germany, Brazil, France, Italy, Canada, India, and Mexico included—the ground keeps shifting. Tighter supply and rising demand for plant-based, sustainable squalene signal longer-term price pressure, but also drive new investment in extraction and distribution, not just in China but in smaller factories in Spain, Australia, or Vietnam. The next two years promise no return to cheap, easy supply, but new manufacturing alliances, smarter tracking of raw material movements, and stronger ties between producers and the world’s biggest buyers hold the most promise.